Methods
Two hundred and sixty-eight women who gave birth to a live infant between August and October 2016 participated in a telephone survey of vaccines received in their most recent pregnancy. For women who reported receiving influenza and/or pertussis vaccine and whose vaccination status was documented by their vaccine provider, MNS vaccination data were compared with the vaccine provider's record as the 'gold standard.' For women who reported receiving no vaccines, MNS vaccination data were compared with self-reported information.
Results
Influenza and pertussis vaccination status was complete (i.e. documented as either vaccinated or not vaccinated) for 66% and 63% of women, respectively. Sensitivity of MNS influenza vaccination data was 65.7% (95% CI 56.0-74.2%) and specificity was 53.0% (95% CI 42.4-63.4%). Sensitivity of MNS pertussis vaccination data was 62.5% (95% CI 53.3-70.9%) and specificity was 40.4% (95% CI 27.6-54.7%). There was no difference between vaccinated and unvaccinated women in the proportion of MNS records with missing or unknown vaccination information. When considering only MNS records with complete vaccination information, the sensitivity of the MNS influenza vaccination field was 91.8% (95% CI 83.0-96.9%) and the sensitivity of the MNS pertussis vaccination field was 88.0% (95% CI 76.7-95.5%).
Conclusion
Due to the high proportion of records with missing or unknown vaccination status, we observed low sensitivity and specificity of antenatal vaccination data in the MNS. However, given we did not observe differential ascertainment by vaccination status, MNS records with complete information may be reliable data source for routinely monitoring antenatal vaccine coverage.
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Introduction
Influenza and pertussis-containing vaccines are routinely recommended for pregnant women in Australia 1 and other developed countries 2-4 , as seasonal influenza vaccine can prevent up to 63% of influenza infections in infants and 36% of febrile respiratory illnesses in pregnant women 5, 6 and antenatal pertussis vaccination can prevent up to 91% of infections in infants <2 months of age. [7] [8] [9] [10] Despite these benefits, uptake of influenza and pertussis vaccines by pregnant women in Australia and other countries has been suboptimal. [11] [12] [13] [14] Recently published estimates in Western Australia suggest that fewer than 50% of pregnant women received an influenza vaccine in 2014 15 and in 2015, 62% of Aboriginal women received an influenza vaccine; 63% received a pertussis vaccine. 16 To improve vaccine coverage in Australia, routine monitoring of vaccine coverage in pregnant women will be needed to inform targeted vaccine promotion strategies. Unfortunately, Australia does not currently have a routine national data collection for monitoring vaccine uptake in pregnancy. We investigated the potential use of the mandatory Midwives Notification System (MNS) in Western Australia as a tool for routine monitoring of antenatal influenza and pertussis vaccination coverage.
Methods
The MNS is a mandated perinatal data collection system, capturing information on >99% of births in Western Australia. 17 It includes information on the health of the mother and neonate, including pregnancy and labour complications and procedures during pregnancy. The 'Notification of Case Attending' form is used to provide this information and is completed by the first medical professional attending the birth (typically a midwife). In July 2016, 4 additional variables were introduced to the 'Notification of Case Attending' form to collect influenza and pertussis vaccination status and the trimester of vaccination during pregnancy. 18 This information is now maintained as part of the MNS.
Since 2012, the Department of Health Western Australia has conducted annual surveys of antenatal vaccination coverage. 15 In brief, a random sample of women aged ≥18 years who gave birth to a live infant between April and October are selected and sent a letter describing procedures opting-out. Women who do not opt-out are contacted by telephone and asked to provide sociodemographic information, whether a provider recommended any vaccines to them, whether they received any vaccines, and reasons why they were or were not vaccinated. For vaccinated women, permission was obtained to contact their immunisation provider to verify their vaccination record.
We requested vaccination fields from the MNS for all women who participated in the survey and gave birth in August 2016 (at least one month after the introduction of the mandatory vaccination field) through October 2016. We verified the vaccination information obtained from the MNS against the woman's self-reported and medically-verified vaccination status (vaccinated women) and against the woman's self-reported vaccination status (unvaccinated women). Vaccinated women were those who self-reported receiving a vaccine during pregnancy and whose nominated vaccination provider confirmed the vaccination record. Unvaccinated women were those who self-reported receiving no vaccine during pregnancy. Using this information, we estimated the positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity of vaccination information obtained from the MNS, overall and by trimester of vaccination (influenza only) and the woman's antenatal care provider. Supplementary analyses estimated sensitivity and specificity after excluding incomplete vaccination fields in the MNS. Women whose vaccination status in their MNS record was either 'vaccinated' or 'not vaccinated', i.e. not 'missing' or 'unknown', were considered as having complete vaccination information in the MNS. To investigate whether data recorded in the MNS as missing or unknown vaccination status were distributed randomly among vaccinated and unvaccinated women, we performed chi-square analyses comparing characteristics of women with complete vaccination information in the MNS to women with missing unknown vaccination status in the MNS. This study was approved by the WA Department of Health's Human Research Ethics Committee (approval # 2015/29).
Results
A total of 277 women completed the telephone survey. Nine women were excluded because they had missing demographic information (n=5) or did not self-report a vaccination status (n=4). Information from the remaining 268 participating women was available for the final validation analysis ( Figure 1 ). Of the 185 women who selfreported receiving seasonal influenza vaccine, 178 gave permission to verify their vaccination details with their immunisation provider, 102 of which were successfully verified. Of the 268 women who self-reported receiving a pertussis vaccine during pregnancy, 215 gave permission to verify their vaccination record, 112 of which could be confirmed by the immunisation provider. The final sample for the validation analysis included the vaccination records of 212 women: 185 in the analysis of influenza vaccination (102 vaccinated, 83 non-vaccinated) and 159 in the analysis of pertussis vaccination (112 vaccinated, 47 unvaccinated). Of the 76 influenza and 103 pertussis vaccinations that were not verified, reasons for lack of verification included incorrect or insufficient contact details for vaccination provider, no response from vaccination provider after at least 3 contact attempts by telephone and email over at least 3 weeks, and in cases where the provider was contacted, the provider could not confirm the vaccination record. The characteristics (for which state-wide data were available) of women who completed the survey were similar to the characteristics of women who gave birth in the state during the study time period (Table 1) .
Influenza vaccine
Among the 185 women included in the influenza vaccination analysis, complete information was obtained from the MNS for 123 women (66%) (73/102 [72%] vaccinated, and 50/83 [60%] unvaccinated, women), P=0.12 ( Table 2 ). The remainder had missing or unknown vaccination status (Table 3 ). There was no difference in the proportion of MNS records with missing or unknown vaccination status between influenzavaccinated and unvaccinated women (P=0.12) ( Table 2 ). However, vaccination information in the MNS was more frequently missing for women who received most of their antenatal care from a private obstetrician or midwife (P=.001). Forty of 61 (65.6%) influenza vaccination records with gestation at time of influenza vaccination had the correct gestation recorded in the MNS.
The sensitivity of the MNS was 65.7% (95% CI 56.0-74.2%) and the specificity was 53.0% (95% CI 42.4-63.4%) ( 
Pertussis vaccine
Among the 159 women included in the pertussis vaccination analysis, complete information was obtained from the MNS for 100 women (63%) (74/112 [66%] vaccinated, and 26/47 [55%] unvaccinated, women) ( Table 2 ). The remainder had missing or unknown vaccination status 
Discussion
We observed low sensitivity and specificity of influenza and pertussis vaccination information obtained from the MNS as compared with self-reported information and vaccine provider records due to 28-34% of MNS vaccination fields having missing or unknown vaccination status. After excluding women with missing or unknown vaccination status in the MNS, we observed high sensitivity and specificity. Given MNS vaccination fields were not differentially missing or unknown for vaccinated women compared to unvaccinated, vaccination data from complete records in the MNS are a potential data source for routinely monitoring antenatal vaccine coverage. However, more complete documentation of MNS vaccination fields would facilitate improved use of these MNS data for monitoring antenatal vaccine coverage.
The proportion of women giving birth in Western Australia with complete antenatal influenza and pertussis vaccination information in the MNS has increased since these data fields were introduced in July 2016. Between September 2016 and September 2018, completeness increased from 65% to 84% for the influenza vaccination field 19 and from 66% to 84% for the pertussis vaccination field 20 ; this may be due to better data recording and/or improvements to data entry processes. Although vaccination status was a mandated field at the time of this study, since this study's completion, the MNS system has been reconfigured to prevent blank vaccination fields, i.e. antenatal influenza and pertussis vaccination status must be recorded as 'vaccinated', 'not-vaccinated' or 'unknown'. Further improvement in the completeness of reporting the MNS vaccination fields (i.e. reducing the 'unknowns') is still possible and should be encouraged.
Findings from this study suggest a mandatory vaccination field in the MNS would offer better sensitivity and specificity compared to nonmandatory, purpose-built antenatal vaccination data collections. 21 The Western Australian Antenatal Vaccination Database relied on passive reporting by immunisation providers of vaccines administered to pregnant women to the Western Australia Department of Health. A previous evaluation of this database found that although the specificity of this system exceeded 99%, its sensitivity was low (48%). 21 In contrast to non-mandatory, purpose-built antenatal vaccination data collections, a mandatory vaccination field in the MNS and equivalent data collection systems in other jurisdictions could allow for surveillance of antenatal vaccination nationally. However, given that sensitivity has been consistently lowest for women who receive private antenatal care as measured by both nonmandatory database and the MNS data capture may be poorer for some groups of women.
Vaccination fields in the MNS are completed at, or soon after, birth so the quality of the vaccination information in a perinatal data collection is likely to depend on access to the woman's vaccination records and ability/willingness to obtain self-reported vaccination status from recently-delivered mothers. Given this, there are several opportunities to further improve the quality and usability of vaccination information in perinatal data collections. First, the National Handheld Pregnancy Record provides a paper-based record of vaccines received during pregnancy. 22 Promoting use of this record may allow medical professionals completing vaccination fields in perinatal data collections to more readily complete this information. Second, retrievable electronic records which maintain vaccination information are useful for providing vaccination information. These are available in cases when the woman is delivering in the hospital where she received the majority of her care, but may not necessarily be available in other settings. Third, promoting entry of antenatal vaccinations by all immunisation providers (both public and private) on the Australian Immunisation Register (AIR) and ensuring medical professionals can access these records would allow consistent electronic recording of antenatal vaccination. 23 Recording in AIR offers several advantages, including: 1) it is a national register; 2) the records are retrievable by multiple health providers; and 3) it is the system currently used to routinely monitor coverage for most government-funded vaccines. Providing training to midwives who complete perinatal data collection records on additional sources of vaccine information for pregnant women, such as AIR and the National Handheld Pregnancy Record, is likely to be helpful. However, it needs to be remembered that AIR neither records pregnancy status at the time of vaccination nor provides denominator data about the total number of pregnant women eligible for antenatal vaccination, so it cannot be used alone to monitor antenatal vaccination coverage. Fourth, midwives should be made aware that self-report has been shown to be an accurate and valid method of ascertaining antenatal vaccination status, in both Aboriginal 16 and non-Aboriginal 15, 24 women, so it is reasonable to record a woman's self-reported vaccination status in the MNS without seeking confirmation from a medical record or AIR. Fifth, enabling midwives to enter antenatal vaccinations into the MNS throughout pregnancy could improve data quality. A recent Australian study has suggested this could improve the completeness of antenatal vaccination records. 25 At time of writing, 4 Australian states collect antenatal vaccination information as part of the state perinatal data collection: Queensland, Victoria, New South Wales, and Western Australia. 26, 27 However, each jurisdiction collects the data slightly differently and antenatal vaccination is not included in the national perinatal data collection. 28 Currently, there remain substantial gaps in routinely available information on national antenatal vaccine coverage which should be addressed because these data could be used to inform current antenatal vaccination programs and, given the apparent safety and immunogenicity of pertussis vaccination at birth 29 , to identify babies who could benefit from this intervention. In view of the benefits of antenatal vaccination to both mothers and infants and the currently suboptimal uptake of these vaccines among pregnant women, routine monitoring of antenatal vaccination is essential for promoting maternal and infant health in Australia.
